About Roy Prieb
Form D filings for CytoAgents in 2023 list Roy Prieb as chief financial officer.
Roy Prieb first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Roy Prieb in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Roy Prieb works with at each company, as listed on that company's latest Form D.
CytoAgents, Inc. · Form D, May 16, 2023
RF
Robert Ferris
Director
SM
Stanley Marks
Director
TW
Teresa Whalen
Chief Executive Officer and President, director
AM
Anthony McCarley
Director
CM
Catherine Mott
Director